Top Markets
#1 DogBull DogBull +73.24%
#2 Siren Siren +31.98%
#3 Verus Coin Verus Coin +14.24%
#4 OriginTrail OriginTrail +12.49%
#5 龙虾 (Lobster) 龙虾 (Lobster) +11.71%
#6 COTI COTI +11.22%
#7 PulseChain PulseChain +6.82%
#8 Falcon Finance Falcon Finance +6.58%
#9 Xphere Xphere +5.70%
#10 Concordium Concordium +4.98%
Coin of the day
DogBull DogBull
Instellingen
Taal
DUTCH
Valuta
USD
Thema
AlzeCure Pharma AB AlzeCure Pharma AB

AlzeCure Pharma AB

ALZCUR
Rang in aandelen #22112
AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops... AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are in preclinical trial for the treatment of Alzheimer’s disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain indications; and ACD137, negative allosteric modulator (NAM) of TrkA receptors for osteoarthritic pain indications. The company was founded in 2012 and is based in Huddinge, Sweden.
Aandeelprijs
$0.71707249
Laatst gesynchroniseerd: 2026-08-21
Marktkapitalisatie
$94.14M
Verandering (1 dag)
-3.31%
Verandering (1 jaar)
76.82%
Land
SE
Handel AlzeCure Pharma AB (ALZCUR)

Categorie

Healthcare
Winst voor AlzeCure Pharma AB (ALZCUR)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van AlzeCure Pharma AB bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van AlzeCure Pharma AB van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH